Chemed (CHE) Operating Leases (2019 - 2026)

Chemed's Operating Leases history runs 8 years deep, the most recent figure standing at $104.4 million for Q1 2026.

• In Q1 2026, Operating Leases rose 2.32% year-over-year to $104.4 million; the TTM figure through Mar 2026 stood at $104.4 million (up 2.32% YoY), while the FY2025 annual figure was $102.9 million, up 4.39% from the prior year.
• Operating Leases was $104.4 million for Q1 2026 at Chemed, up from $102.9 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $110.5 million in Q4 2022 to a low of $98.5 million in Q4 2024.
• Historically, Operating Leases has averaged $103.8 million across 5 years, with a median of $103.4 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Operating Leases climbed 10.43% in 2022, then decreased 8.81% in 2023.
• A 5-year view of Operating Leases shows it stood at $110.5 million in 2022, then retreated by 8.81% to $100.8 million in 2023, then slipped by 2.22% to $98.5 million in 2024, then gained by 4.39% to $102.9 million in 2025, then climbed by 1.54% to $104.4 million in 2026.
• The last three Operating Leases figures came in at $104.4 million (Q1 2026), $102.9 million (Q4 2025), and $99.5 million (Q3 2025), per Business Quant data.